DVT Prophylaxis Documentation for Chronically Bed-Bound Nursing Home Residents
In chronically bed-bound patients with encephalopathy residing in skilled nursing facilities, you should document that routine DVT prophylaxis is NOT indicated and explain why, rather than documenting prophylaxis administration. 1, 2
The Core Recommendation
Both the 2012 ACCP and 2018 ASH guidelines explicitly recommend against routine thromboprophylaxis in chronically immobilized persons residing in nursing homes 1, 2. This is a Grade 2C recommendation, meaning the evidence certainty is low but the guidance is clear: the risks of bleeding and other complications outweigh the uncertain benefits in this population.
What to Document
Your documentation should include:
1. Patient Status Assessment
- Mobility level: "Patient is permanently bed-bound due to chronic encephalopathy"
- Duration of immobility: "Chronically immobilized for [timeframe]"
- Setting: "Long-term resident of skilled nursing facility"
2. Clinical Decision Statement
Document a clear statement such as:
- "Per ACCP 2012 and ASH 2018 guidelines, routine DVT prophylaxis is not indicated for chronically immobilized nursing home residents"
- "Risk-benefit assessment performed: bleeding risk and monitoring burden outweigh uncertain VTE prevention benefit in chronic immobilization setting"
3. Risk Factor Documentation
While prophylaxis isn't routinely indicated, document any additional acute risk factors that might change the equation:
- Recent surgery or trauma
- Active malignancy
- Previous VTE history
- Acute medical illness requiring hospitalization
- Central venous catheters
4. Bleeding Risk Assessment
Document factors that support withholding prophylaxis:
- Fall risk (common in encephalopathy patients)
- Cognitive impairment affecting monitoring
- Polypharmacy
- Renal impairment
- History of bleeding
Critical Distinction: Acute vs. Chronic Immobilization
This is the key clinical pitfall: The guidelines differentiate between:
- Acutely ill hospitalized patients with new immobilization → prophylaxis IS indicated 1, 2
- Chronically immobilized nursing home residents → prophylaxis is NOT routinely indicated 1, 2
If your patient develops an acute medical illness requiring hospitalization, the recommendation changes. During that acute hospitalization, prophylaxis with LMWH, fondaparinux, or UFH would be appropriate 2. Document this transition clearly.
When Prophylaxis Duration Ends
The 2012 ACCP guidelines specifically state: "we suggest against extending the duration of thromboprophylaxis beyond the period of patient immobilization or acute hospital stay" 1. This means:
- If the patient was hospitalized and received prophylaxis, document discontinuation upon return to baseline chronic status
- "DVT prophylaxis discontinued upon return to skilled nursing facility per guidelines for chronically immobilized patients"
Special Circumstances Requiring Reassessment
Document reassessment if:
- Acute hospitalization occurs: Initiate prophylaxis during acute illness, discontinue upon discharge back to SNF
- New cancer diagnosis: Consider prophylaxis if additional risk factors present 1
- Planned surgery: Perioperative prophylaxis indicated, but discontinue post-recovery
- Development of symptomatic DVT/PE: This changes to treatment, not prophylaxis
Evidence Quality Context
The recommendation against prophylaxis in chronically immobilized nursing home residents carries very low certainty evidence 2. However, both major guideline bodies (ACCP 2012 and ASH 2018) reached the same conclusion independently 1, 2. The rationale is that chronic immobilization represents a different risk profile than acute illness, with lower absolute VTE rates and higher bleeding/monitoring risks in this frail population.
Sample Documentation Template
"Patient is chronically bed-bound due to encephalopathy and is a long-term resident of skilled nursing facility. Per ACCP 2012 and ASH 2018 guidelines, routine pharmacologic or mechanical DVT prophylaxis is not indicated for chronically immobilized nursing home residents (Grade 2C recommendation). Risk-benefit assessment performed: patient has [list bleeding risks: fall risk, cognitive impairment, etc.] and no acute provoking factors for VTE. Will reassess if acute medical illness develops requiring hospitalization."
The documentation should justify the absence of prophylaxis rather than its presence, as this aligns with evidence-based practice for this specific population.